Cantor Fitzgerald analysts initates an Overweight rating for ARS Pharmaceuticals Inc (SPRY)
ARS Pharmaceuticals Inc’s recent filing unveils that its Officer Chakma Justin acquired Company’s shares for reported $4.09 million on Nov
ARS Pharmaceuticals Inc’s recent filing unveils that its Officer Chakma Justin acquired Company’s shares for reported $4.09 million on Nov
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
ARS Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Scott Kathleen D. unloaded Company’s shares for reported $0.2
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, ARS Pharmaceuticals Inc revealed its Chief Financial Officer Scott Kathleen D. unloaded Company’s shares for reported $0.2
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, ARS Pharmaceuticals Inc revealed its Chief Financial Officer Scott Kathleen D. unloaded Company’s shares for reported $0.2
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
ARS Pharmaceuticals Inc’s recent filing unveils that its Chief Financial Officer Scott Kathleen D. unloaded Company’s shares for reported $0.2
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.